Important Deadlines

Week beginning 15 April 2019

Notification of abstract scheduling/rejection to submitting authors

Friday, 17 May 2019

Extended deadline for abstract submission

Friday, 24 May 2019

Deadline for registration from presenting authors

Online Abstract Submissions is Now Closed

All accepted abstracts will be scheduled for presentation in poster viewing sessions not overlapping with other elements of the program.

Abstracts within one of the following topics are welcome:

  • Bioinformatics
  • Biomarkers (prognostic and predictive)
  • Cancer prevention
  • Clinical trial design
  • Diagnostics
  • Drug design and discovery
  • Drug resistance and modifiers
  • Early diagnosis of cancer
  • Experimental therapies – clinical
  • Experimental therapies – preclinical
  • Genetics, genomics and proteomics
  • New combinations (agents and modalities)
  • New treatment strategies
  • Patient reported outcomes
  • Preclinical test models

Abstract Guidelines

Please click to see the full abstract submission guidelines.

Publication of Abstracts

All accepted abstracts will be published in an oncology review after the symposium.

Poster Award

All accepted abstract submissions will have the opportunity to compete for the WIN 2019 Best-Poster Awards. Details will be sent with the abstract notifications.

WIN 2019 Symposium
c/o MCI UK Ltd
Durford Mill
GU31 5AZ

Tel: +44 (0) 1730 715223
General enquiries: win2019@mci-group.com
Sponsorship enquiries: win2019industry@mci-group.com
Abstract enquiries: win2019abstracts@mci-group.com
Registration enquiries: win2019reg@mci-group.com

View Our Privacy Policy Here